Mega Lifesciences Share Price Thailand S.E.

Equities

MEGA-R

TH4984010R19

Pharmaceuticals

End-of-day quote Thailand S.E. 23:00:00 24/06/2024 BST 5-day change 1st Jan Change
38 THB +3.40% Intraday chart for Mega Lifesciences +2.70% -5.59%

Financials

Sales 2024 * 16.18B 440M 34.69B Sales 2025 * 17.02B 463M 36.5B Capitalization 33.13B 900M 71.04B
Net income 2024 * 2.53B 68.67M 5.42B Net income 2025 * 2.61B 70.87M 5.59B EV / Sales 2024 * 1.85 x
Net cash position 2024 * 3.15B 85.68M 6.76B Net cash position 2025 * 3.77B 102M 8.09B EV / Sales 2025 * 1.72 x
P/E ratio 2024 *
13.1 x
P/E ratio 2025 *
12.6 x
Employees -
Yield 2024 *
4.58%
Yield 2025 *
4.89%
Free-Float 37.92%
More Fundamentals * Assessed data
Dynamic Chart
Mega Lifesciences Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Transcript : Mega Lifesciences Public Company Limited, 2023 Earnings Call, Feb 23, 2024
Mega Lifesciences Public Company Limited Proposes Dividend for the Year Ended December 31, 2023, Payable on April 22, 2024 CI
Mega Lifesciences Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : Mega Lifesciences Public Company Limited, Q3 2023 Earnings Call, Nov 14, 2023
Mega Lifesciences Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Mega Lifesciences Public Company Limited Announces Cash Dividend for the Period from January 1, 2023to June 30, 2023, Payable on September 8, 2023 CI
Mega Lifesciences Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Transcript : Mega Lifesciences Public Company Limited, Q1 2023 Earnings Call, May 15, 2023
Mega Lifesciences Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Mega Lifesciences Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Transcript : Mega Lifesciences Public Company Limited, 2022 Earnings Call, Feb 24, 2023
Transcript : Mega Lifesciences Public Company Limited, Q3 2022 Earnings Call, Nov 15, 2022
Mega Lifesciences Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Transcript : Mega Lifesciences Public Company Limited, Q2 2022 Earnings Call, Aug 15, 2022
More news
1 day+3.40%
1 week+2.70%
Current month-5.00%
1 month-6.17%
3 months-7.32%
6 months-7.32%
Current year-5.59%
More quotes
1 week
36.00
Extreme 36
38.00
1 month
35.75
Extreme 35.75
40.50
Current year
35.75
Extreme 35.75
44.25
1 year
35.50
Extreme 35.5
46.75
3 years
34.75
Extreme 34.75
56.50
5 years
17.90
Extreme 17.9
56.50
10 years
15.00
Extreme 15
56.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 31/12/85
Director of Finance/CFO 59 31/12/96
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member 53 12/05/21
Founder 70 31/12/81
Director/Board Member 67 31/01/13
More insiders
Date Price Change Volume
25/06/24 38 +3.40% 933,800
24/06/24 36.75 +0.68% 3,255,500
21/06/24 36.5 +0.69% 1,149,200
20/06/24 36.25 -0.68% 1,741,600
19/06/24 36.5 -1.35% 1,356,200

End-of-day quote Thailand S.E., June 24, 2024

More quotes
Mega Lifesciences Public Company Limited is a Thailand-based company. The Company is engaged in manufacturing and selling through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins and fast-moving consumer goods, as well as the provision of distribution services relating to such products. Its segments include Brands, Distribution, and OEM (Original Equipment Manufacturer). The Brands segment represents a business segment in which goods are manufactured and sold under brands owned by the Company. The Distribution segment represents a service business segment in which the Company provides logistical and marketing services for goods trading purposes and the sale of goods manufactured by third parties. The OEM segment represents a business segment in which goods are manufactured by third parties under brands not owned by the Company.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
38 THB
Average target price
48.88 THB
Spread / Average Target
+28.62%
Consensus